Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT05874401
Title Trilaciclib vs Placebo in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC) Receiving Topotecan
Recruitment Recruiting
Gender both
Phase FDA approved
Variant Requirements No
Sponsors G1 Therapeutics, Inc.
Age Groups: adult | senior
Covered Countries ESP | DEU | BEL | AUT

No variant requirements are available.